| CAS NO: | 439153-64-7 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 20mg | 电议 |
| Cas No. | 439153-64-7 |
| 别名 | (Rac)-LNK-754; (Rac)-OSI-754 |
| Canonical SMILES | O=C1N(C)C2=C(C=C(C(O)(C3=CC=C(Cl)C=C3)C4=CN=CN4C)C=C2)C(C5=CC=CC(C#C)=C5)=C1 |
| 分子式 | C29H22ClN3O2 |
| 分子量 | 479.96 |
| 溶解度 | Soluble in DMSO |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | LNK754 is a farnesyltransferase inhibitor, used for the treatment of cancer and Alzheimer's disease. LNK-754 (0.9 mg/kg) significantly reduces α-synuclein plaques in a mouse model of PD, APP(SL), at 6 months of age for 3 months[1]. [1]. Keith T Gagnon. HD Therapeutics-CHDI Fifth Annual Conference. IDrugs. 2010 Apr;13(4):219-23. |
m.cnreagent.com